1Globe Capital LLC 13D and 13G filings for Crescent Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-14 3:41 pm Purchase | 2025-10-07 | 13G | CRESCENT BIOPHARMA, INC CBIO | 1Globe Capital LLC | 1,425,432 10.300% | 528,720 (+58.96%) | Filing |
| 2025-08-20 5:20 pm Purchase | 2025-08-13 | 13G | CRESCENT BIOPHARMA, INC CBIO | 1Globe Capital LLC | 896,712 6.450% | 896,712 (New Position) | Filing |